Abstract. Hepatitis B virus (HBV) X protein (HBx) plays a key role in the initiation and progression of HBV infection-induced hepatocellular carcinoma (HCC). Oncogenic microRNA-21 (miR-21) can be modulated by HBx protein in HCC. However, critical regulator genes in the pathway of HBx-induced miR-21 in HCC remain unclear. This study aimed to investigate the role of HBx-induced miR-21 in the apoptosis of HCC cells. In the study, interleukin-12 (IL-12) was demonstrated as a direct target of miR-21 by dual-luciferase report assay, and miR-21 was highly expressed in HCC cells (HepG2 and HepG2 2.2.15) compared to L02 cells, but IL-12 was weakly expressed as detected by real-time quantitative PCR (RT-qPCR). Furthermore, miR-21 mimics, inhibitor, HBx-targeted siRNA, and the HBx overexpression vector (pHBx) were used to observe the regulatory effects of HBx-induced miR-21 via IL-12, and cell apoptosis was assessed. The results showed that overexpression of HBx resulted in the inhibition of IL-12. A high level of miR-21 resulted in a significant increase in proliferation and a decrease in IL-12 expression. Inhibition of miR-21 resulted in a significant increase in apoptosis and increased IL-12 expression. The results suggest that HCC cell apoptosis was suppressed at least partially through HBx-induced miR-21 by targeting IL-12.
Introduction
Chronic infection by hepatitis B virus (HBV) is strongly associated with the initiation and progression of hepatocellular carcinoma (HCC) (1, 2) , and HBV X protein (HBx) is a major risk factor in the molecular pathogenesis of HBV-related HCC (3, 4) . HBx is encoded by the HBV genome, and it is required for mammalian hepadnavirus infectivity and replication (5) . In human hepatocytes, HBx has multiple molecular functions by interacting with different transcription factors and modulating numerous cellular signaling pathways (6) (7) (8) .
microRNAs (miRNAs) are a class of endogenous small RNAs 19 to 23 nucleotides (nt) in length, which have been studied as regulators of gene expression in biological processes, including cell development, differentiation, apoptosis, and proliferation (9) . Recent studies have shown that HBx protein can induce the differential expression of miRNAs, such as miR-520 (10), miR-145, miR-222, miR-21 (11) and miR-146 (12) . Oncogenic miR-21 was reported as an important miRNA induced by HBx, and promotes cell proliferation (13) and transformation (14) , but the related mechanism is not yet fully elucidated.
Interleukin-12 (IL-12) was discovered as a 'natural killer-stimulating factor' and a 'cytotoxic lymphocyte maturation factor' (15, 16) . IL-12 is produced by monocytes, macrophages, B cells and dendritic cells. IL-12 is known as a T cell-stimulating factor, which can stimulate the production of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) from T cells and natural killer (NK) cells, and favors the differentiation of naive CD4 + T cells into mature Th1 cells (17) . Studies have reported that IL-12 as a cytokine has antitumor therapeutic activities, and it has been shown to inhibit tumorigenesis and induce regression of established tumors. IL-12 promotes the effective destruction of cancer cells by inducing proliferation of NK and T cells, and IL-12 enhances the generation and activity of cytotoxic T lymphocytes (CTLs) (18, 19) . In addition, several other mechanisms of IL-12 strongly contribute to antitumor activities (20, 21) , and the antitumor activity of IL-12 can be improved by its combination with various therapeutics (22, 23) .
In this study, we first report that IL-12 was regulated by HBx-induced miR-21 in human hepatocytes, especially in HCC cells. The study aimed to reveal the role of HBx-induced miR-21 and IL-12 in HCC biology. miR-21 mimics and the inhibitor were transfected into cells for upregulation or downregulation, respectively, of miR-21 expression, and an miR-21 sequence-scrambled RNA was used as the miRNA negative control (NC_miR). Pre-designed siRNAs were used to inhibit the expression of HBx. cDNA of HBx cloned into the pEGFP-N3 vector (Clontech Laboratories, Mountain View, CA, USA) was used as an HBx transgene (pHBx) in hepatic cells, and an empty vector (vector) was used as a negative control. The cells were transfected in vitro with the miRNAs, siRNAs and plasmids using Lipofectamine ® 2000 transfection reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. miR-21 mimics, inhibitor, siRNAs and negative control were obtained from Biomics Biotechnologies Co., Ltd. (Nantong, China) and the sequences are shown in Table I .
Materials and methods

Cell
Dual-luciferase reporter (DLR) assay. The cDNA of the 3'UTR region of IL-12 mRNA was constructed into the pGL3-vector (Promega Corp., Madison, WI, USA) as a dual-luciferase miRNA target expression vector (pGL3-IL-12 3'UTR wild-type) to evaluate miR-21 activity. The IL-12 3'UTR mutant vector was also constructed as the negative control (pGL3-IL-12 3'UTR mutant). HEK293 cells were seeded in a 24-well plate. After 24 h, the cells were co-transfected with pGL3-IL-12 3'UTR wild-type or mutant vector and miR-21 mimics or NC_miR; pRL-TK (Promega Corp.) was co-transfected as internal control. Luciferase activities were measured 48-h post-transfection using the DLR assay system (Promega Corp.) according to the manufacturer's instructions.
Real-time quantitative PCR (RT-qPCR).
Total RNA of the hepatocytes for mRNA detection was extracted using TRIzol ® reagent (Thermo Fisher Scientific). Small RNA enriched with miRNAs was isolated using mirPremier ® microRNA isolation kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer's instructions.
Stem-loop RT-qPCR was performed for miR-21 expression detection as described previously (24) , U6 small RNAs were used as an internal control (25) . RT-qPCR was carried out using the SuperScript ® III Platinum ® SYBR ® Green
One-Step RT-qPCR kit (Thermo Fisher Scientific) according to the manufacturer's instructions. The relative expression was evaluated by the 2 -ΔΔCt method (26) . The primer sequences are shown in Table II .
Western blot analysis. Cells were plated in 6-well plates and treated as described above. Post 48-h treatment, the cells were harvested and lysed in ice-cold cell RIPA lysis and extraction buffer (Thermo Fisher Scientific). After centrifugation for collecting, the proteins were separated by polyacrylamide gel electrophoresis and electro-transferred to polyvinylidene fluoride (PVDF) membranes (Millipore Corp., Billerica, MA, USA), and then incubated with the anti-IL-12 (1:1,000 dilution), anti-HBx antigen (1:1,000 dilution) or mouse anti-human β-actin antibody (1:5,000 dilution) (all from Abcam, Cambridge, MA, USA) as internal control. After washing with TBST, the membrane was incubated with horseradish peroxidase (HRP)-conjugated secondary antibody for 1.5 h at room temperature, and then washed in TBST. Finally, the specific proteins were detected with ECL substrate (Thermo Fisher Scientific).
Cell proliferation assay. Cell proliferation was measured using the Vybrant ® MTT Cell Proliferation assay kit (Thermo Fisher Scientific). Hepatocytes were seeded on a 96-well plate at a concentration of 5x10 3 cells/well before transfection and grown to about 70% confluency for 24 h. After treatments for 0, 24, 48, 72 and 96 h, the medium was removed and replaced with 100 µl of fresh culture medium, and then 10 µl of the 12 mmol/l MTT stock solution was added to each well. A negative control of 10 µl of the MTT stock solution added to 100 µl of medium alone was included. After incubation at 37˚C for 4 h, 100 µl of the SDS-HCl (0.01 mol/l) solution was added to each well and mixed thoroughly. The microplate was incubated at 37˚C for 4 h in a humidified chamber. Each sample was mixed again and the absorbance was read at 570 nm using a microplate reader (BioTek, Winooski, VT, USA).
Cell apoptosis assay. Cell apoptosis following the different treatments was determined by flow cytometric (FCM) analysis with Annexin V-FITC/PI double staining. Briefly, post 48-h treatments as described above, 1x10 5 cells/well were harvested and washed in phosphate-buffered saline (PBS) in a 6-well plate, then re-suspended in Annexin-binding buffer, followed by incubation with Annexin V-FITC conjugate and PI for 15 min at room temperature. The stained cells were detected by FCM, and the results were analyzed by BD CellQuest software (BD Biosciences, Franklin Lakes, NJ, USA).
Statistical analysis.
All the experiments were performed independently three times. The data are shown as mean values ± standard deviation (SD). Statistical analyses were performed using SPSS 19.0 software, and the results were analyzed using one way ANOVA followed by post hoc test to assess statistical significance. All P-values are based on a two-sided statistical analysis and P<0.05 was considered to indicate statistical significance. 12 mRNA is a direct target of miR-21 . miRNA target predication software was used to identify the potential miRNAs which regulate IL-12 in TargetScan database (http:// www.targetscan.org/). A putative miR-21 binding site was predicted in the 3'UTR region of IL-12 mRNA (Fig. 1A) . To investigate the regulatory effects of miR-21 on IL-12, pGL3-IL-12 3'UTR wild-type and mutant vector were constructed (Fig. 1B) . The results of the DLR assay showed that co-transfection of HEK293 cells with the miR-21 mimics (miR-21) and pGL3-IL-12 3'UTR wild-type or mutant vector, led to an obvious reduction in luciferase activity compared to the NC_miR (Fig. 1C) . In contrast, the luciferase activity of the pGL3-IL-12 3'UTR mutant vector was not affected by upregulation of miR-21 (Fig. 1C) , which further validated the direct binding between the miR-21 seed sequence and 3'UTR of IL-12 mRNA, and indicates that IL-12 is a novel direct target of miR-21. Fig. 2A) , while the mRNA level of IL-12 in the Fig. 2) showed that miR-21 was weakly expressed in the L02 cells, and there was no HBx expression. As shown in Fig. 3 , the expression level of miR-21 was significantly upregulated post-miR-21 mimic or HBx overexpression vector (pHBx) transfection compared with that in the NC_miR or vector-treated group (P<0.05; Fig. 3A) . The protein level of IL-12 was obviously decreased in the miR-21 and pHBx-treated group compared with the levels in the NC_miR or vector-treated group (P<0.05; Fig. 3B ). 4A ). The mRNA and protein levels of IL-12 were both decreased in the pHBx-treated cells as detected by RT-qPCR and western blot analysis separately (Fig. 4B and C) . Fig. 2B . The effects of the regulation of IL-12 by miR-12 when HBx or miR-21 is downregulated or upregulated were observed. Compared with the NC_siR-treated cells, miR-21 was significantly decreased in the HBx_siR1-treated cells (Fig. 6A) . The mRNA and protein levels of IL-12 were both increased in the HBx_siR1-treated cells (Fig. 6B and C) . To inhibit miR-21, the miR-21 inhibitor was used. The results showed that, compared with the NC_miR-treated cells, miR-21 was significantly decreased in the miR-21 inhibitor- treated cells (Fig. 7A) , while the protein level of IL-12 was increased (Fig. 7B) .
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HepG2 2.2.15 cells with high HBx expression were used to observe cell proliferation affected by HBx or miR-21 by MTT assay. Compared with the vector-treated cells, the results showed that the proliferation ability of the HepG2 cells was increased after treatment with pHBx (Fig. 8A) . Compared with the NC_miR or NC_siR-treated cells, the proliferation ability of the HepG2 2.2.15 cells was decreased after treatment with the miR-21 inhibitor or HBx_siR1 (Fig. 8B) .
In addition, the role of HBx or miR-21 on the apoptosis of HepG2 2.2.15 cells was examined by FCM analysis with Annexin V-FITC/PI double staining. Compared with the NC_miR or NC_siR-treated cells, treatment with the miR-21 inhibitor or HBx_siR1 resulted in a significant increase in apoptosis (P<0.05; Fig. 8C and D) .
Discussion
IL-12 used as an anticancer therapeutic in several clinical trials has demonstrated beneficial results by gene therapy, and currently antitumor studies based on IL-12 are ongoing with the key focus of reducing toxicities and side effects (27) (28) (29) . Undoubtedly, cancer treatment using direct administration of IL-12 protein or IL-12 expression vector is preferred, but the production of IL-12 protein or IL-12 gene delivery is problematic to define. In the present study, we aimed to identify an optional route for the cell endogenous IL-12-inducing pathway in HCC, especially in HBx-related HCC.
HBx plays an important role in the development of HBV-related HCC (30) . HBx has been shown to induce various signaling pathways and cellular proteins that could link HCC with HBV infection (31) (32) (33) . Studies have shown that HBx protein induces the expression of oncogenic miR-21, but the molecular mechanism of the role of miR-21 in HBx-induced proliferation and apoptosis in HCC cells is still unknown. In this study, we investigated the effect of HBx on the expression of miR-21 and its role in inducing the proliferation and apoptosis induced by targeting IL-12 in HCC cells.
The results of our study showed that IL-12 is a direct target of miR-21 by binding to 3'UTR of IL-12 and DLR assay validation (Fig. 1) . Furthermore, HepG2 cells with no HBx expression, and HepG2 2.2.15 cells with high expression of HBx (Fig. 2C) were used as an HCC in vitro cell model, and normal hepatocyte L02 cells were used as a control. The result of RT-qPCR showed that miR-21 was highly expressed in both HepG2 and HepG2 2.2.15 cells compared with the L02 cells ( Fig. 2A) , while IL-12 was weakly expressed in the two HCC cell lines (P<0.05; Fig. 2B ). In the L02 cells with low miR-21 and no HBx expression, the expression of IL-12 was downregulated significantly after miR-21 was increased or HBx was overexpressed (Fig. 3) . In the HepG2 cells with no HBx, overexpression of HBx resulted in significant miR-21 upregulation (Fig. 4A) . Upregulation of HBx resulted in a decrease in the mRNA and protein levels of IL-12 ( Fig. 4B and C) . In the HepG2 2.2.15 cells with high expression of HBx and high miR-21 level, HBx inhibited by siRNAs resulted in a significant decrease in miR-21 (Fig. 6A) . The mRNA and protein levels of IL-12 were both increased ( Fig. 6B and C) . miR-21 inhibited by the miR-21 inhibitor resulted in the increase in the protein level of IL-12 (Fig. 7) . These results showed that IL-12 is regulated by HBx-induced miR-21.
Previous studies have shown that HBx inhibits apoptosis and enhances cellular proliferation in hepatoma cells (34, 35) , while the mechanism is unknown. Thus, further validation by MTT assay and FCM analysis showed that the proliferation ability of the HepG2 cells was increased when HBx was overexpressed (Fig. 8A) . The proliferation ability of the HepG2 2.2.15 cells was decreased when miR-21 was inhibited by the miR-21 inhibitor or HBx_siR1 (Fig. 8B) . Treatment with miR-21 inhibitor or HBx_siR1 resulted in a significant increase in HepG2 2.2.15 cell apoptosis (Fig. 8C and D) .
Our study confirmed that IL-12 is a direct target of miR-21 and miR-21 can be upregulated by HBx protein in hepatic cells. A high level of HBx also resulted in the inhibition of IL-12. A high level of miR-21 resulted in a significant decrease in IL-12 expression and an increase in proliferation. Inhibition of miR-21 resulted in a significant increase in IL-12 expression and an increase in apoptosis. The results suggest that the suppression of apoptosis in HCC cells was at least partially carried out through HBx-induced miR-21 by targeting IL-12.
